[CLINICAL STUDIES ON STREPTOMYCIN DEAFNESS].
D000255:Adenosine Triphosphate; D001299:Audiometry; D002807:Chondroitin; D003051:Cochlea; D003638:Deafness; D004096:Dihydrostreptomycin Sulfate; D004112:Dimercaprol; D004358:Drug Therapy; D007273:Injections, Intramuscular; D007278:Injections, Spinal; D007564:Japan; D009525:Niacin; D009539:Nicotinic Acids; D010205:Pantothenic Acid; D010862:Pilocarpine; D011379:Prognosis; D013223:Statistics as Topic; D013307:Streptomycin / Q000009:adverse effects*; D014116:Toxicology; D014722:Vestibule, Labyrinth; D014815:Vitamins
D009539:Nicotinic Acids; D014815:Vitamins; D010862:Pilocarpine; D004112:Dimercaprol; D010205:Pantothenic Acid; D009525:Niacin; D000255:Adenosine Triphosphate; D002807:Chondroitin; D004096:Dihydrostreptomycin Sulfate; D013307:Streptomycin
ADENOSINE TRIPHOSPHATE; AUDIOMETRY; CHONDROITIN; COCHLEA; DEAFNESS; DIHYDROSTREPTOMYCIN; DIMERCAPROL; DRUG THERAPY; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRATHECAL; JAPAN; NICOTINIC ACID; PANTOTHENIC ACID; PILOCARPINE; PROGNOSIS; STATISTICS; STREPTOMYCIN TOXICOLOGY; TOXICOLOGIC REPORT; VESTIBULAR APPARATUS; VITAMINS